Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.


CSE:BNXT - Post by User

Comment by gemsearcher2on Dec 17, 2020 4:53pm
107 Views
Post# 32130964

RE:launch in European markets are planned for Q1 2021.

RE:launch in European markets are planned for Q1 2021.I did not kow that q1 begins april 01.. really?
Perhaps i am missing something but if so... then why are the last SEDAR quarterly reports for Q3 2020 that are dated as being filed Nov. 30,2020 shown as being for the 9 month period ended September 30th? ie: XPHYTO THERAPEUTICS CORP.Management’sDiscussion and AnalysisFor the three and nine months ended September 30, 2020

that would be the third quarter correct? if so,, then q1 2021 begins Jan 01,2021 right?

I am not here to argue but i just wish you would explain for me at least why you say that q1 begins april 01 and not jan.01,, thanks
PS--yes there ought to be a lot of vaccinations done by that time!.. and it may be a little late to arrive with a good product but i tend to believe that there will still be a market for rapid cov and sars tests for a long time to come especially in some of the eastern bloc countries and others..
But what will be will be.. i still believe it is a helpful test to have developed.
thanks! gs2


<< Previous
Bullboard Posts
Next >>